Fernandez Hospital ’s Post

✨New Publication Alert!✨ We are proud to share findings from the study, "Risk Factors and Maternal and Fetal Outcomes in Gestational Diabetes Mellitus at a Tertiary Care Center in Hyderabad – A Retrospective Study" by Drs Asma Shaheen, Latha Sashi and others. It examines the risk factors associated with Gestational Diabetes Mellitus (GDM) and its effects on maternal and fetal outcomes. 👶 Key Risk Factors: 💡Advanced maternal age 💡Higher BMI before pregnancy 💡Multiple pregnancies With early screening, personalised care, and effective management, both maternal and fetal outcomes can be significantly improved. By adopting a healthy diet and lifestyle, along with multidisciplinary support, women with GDM can manage their condition and achieve better results.🤗 Let’s raise awareness about the importance of early screening and comprehensive care for GDM! 🌸 #GestationalDiabetes #MaternalHealth #FetalHealth #DiabetesAwareness #PublicHealthResearch #HyderabadHealth #MaternalOutcomes #HealthEducation #DiabetesCare #HealthyPregnancy

NATIONAL GESTATIONAL DIABETES MELLITUS (GDM) DAY #2024 Dr. Meenakshi Bajaj mam, invaluable insights and knowledge making it worthy learning and comprehensive understanding of GDM. ☑️ "Two Lives: Twice as Precious" offer evidence-based insights into medical nutrition for hyperglycemia during pregnancy, contributing significantly to raising awareness about gestational diabetes mellitus (GDM) and its potential impact on maternal and fetal health. ☑️These resources provide practical recommendations for nutritional management, empowering pregnant women with essential knowledge to effectively address their condition. ☑️Furthermore, healthcare professionals can utilize these resources to enhance their understanding of GDM, ultimately improving patient care and outcomes. ☑️In essence, works like "Two Lives: Twice as Precious" play a crucial role in promoting awareness and facilitating better management of GDM for expectant mothers and their infants. Thank you mam🙏🏻Dr Meenakshi Bajaj #Nationalgestationaldiabetesmellitus #10March2024 Is now available in amazon Link: https://amzn.eu/d/9qHBsgZ

Numerous studies highlight the significance of birth size in determining lifelong health risks. A smaller birth size is associated with an increased risk of cardiometabolic diseases during both childhood and adulthood. Additionally, rapid growth in early life is linked to adverse health outcomes. Identifying modifiable factors that influence the fetal environment can help target interventions for expectant mothers. Maternal behaviors during pregnancy, including levels of physical activity and sedentary behavior, play a crucial role in fetal growth. For instance, higher levels of maternal sedentary behavior during pregnancy have been linked to a lower birth ponderal index, indicating potential impacts on placental nutrient transport and birth size. For in-depth understanding please refer the publication below: Jones M.A., Catov J.M., Jeyabalan A., Whitaker K.M., Barone Gibbs B. Sedentary behaviour and physical activity across pregnancy and birth outcomes. Paediatr. Périnat. Epidemiol. 2021;35:341–349. doi: 10.1111/ppe.12731. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

【Analysis of Gestational Diabetes Mellitus (GDM) and Its Impact on Maternal and Fetal Health: A Comprehensive Dataset Study Using Data Analytic Tool Power BI】 Full article: https://lnkd.in/gxZdXbEm (Authored by Shahistha Jabeen Hashim and Arthur McAdams, from University of Bridgeport, USA.) #Gestational_Diabetes Mellitus (GDM), a condition characterized by irregular glucose levels during pregnancy, is a significant concern during #pregnancy due to its potential health implications for both the mother and the fetus. This study investigates the key risk factors associated with GDM by exploring the demographics of the dataset and employing #data_modeling techniques, and explores the physiological mechanisms underlying GDM and its implications for maternal and fetal health by analyzing various biomarkers. #Visualization #Data_Analytics #Power_BI 

I am so happy to have had the opportunity to be interviewed on this podcast. It’s such a great topic - metabolic dysfunction! All should know about this subject! #metabolism #mitochondria

With the average waist measurement in Australia recorded as 99 centimetres for men and 91 centimetres for women in 2023, the risks of metabolic dysfunction are significant. In our latest podcast with Dr Felice Gersh, MD, obstetrician, gynaecologist and integrative medicine practitioner, we learn about the risks associated with metabolic dysfunction and, as healthcare professionals, how to recognise and prevent it in our patients. Joined by fx Medicine ambassador Emma Sutherland, Felice discusses metabolism from a cellular level, mitochondrial dysfunction and its connection to insulin sensitivity and hypoglycaemia. As a gynaecologist and obstetrician, Felice connects metabolic and hormonal health with reproductive health outcomes and health across the lifespan including menopause and pregnancy. This podcast is packed with clinical pearls and insights into metabolic dysfunction and is relevant to all healthcare professionals looking to support clients with metabolic health conditions, looking to increase metabolic flexibility and promote health throughout the lifespan. Click on the link below for the full episode, transcript, resources and to sign up for the fx Medicine newsletter - https://lnkd.in/dTHWxz7D #metabolichealth #metabolism #cardiovascularhealth #lifespannutrition #lifespanhealth #reproductivehealth #femalehealth #femalehormone #femalehormonedysfunction #integrativemedicine #healthpractitioner #healthpractitioneradvice #fxmedicine #fxmedicinepodcast #lifestylemedicine #nutritionalsupplementation #naturalmedicine #nutritionalmedicine #foodandlifestyle #lifestylemedicine

🧩 𝐏𝐮𝐳𝐳𝐥𝐢𝐧𝐠 𝐅𝐢𝐧𝐝𝐢𝐧𝐠𝐬 𝐨𝐧 𝐁𝐥𝐨𝐨𝐝 𝐆𝐥𝐲𝐜𝐚𝐭𝐞𝐝 𝐀𝐥𝐛𝐮𝐦𝐢𝐧 𝐋𝐞𝐯𝐞𝐥𝐬 𝐚𝐧𝐝 𝐆𝐞𝐬𝐭𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐃𝐢𝐚𝐛𝐞𝐭𝐞𝐬 In collaboration with Dr. Justine Cole and Dr. David B. Sacks from the National Institutes of Health, researchers from the #GloW team, Dr. Claire Guivarch, Dr. Wei Wei Pang, and Prof. Cuilin Zhang MD, MPH, PhD., have just published a paper exploring the longitudinal associations between glycated albumin — a marker of glycemia, and gestational diabetes mellitus (GDM). Unexpectedly, women who were diagnosed with GDM in later pregnancy had significantly lower mean glycated albumin concentrations in mid-pregnancy than those who did not develop GDM. These surprising findings merit further confirmation in other populations. “Our findings highlight the necessity for further research in order to understand the role of glycated albumin in the development of GDM in different populations” commented Prof. Zhang. Please read more here: https://lnkd.in/g3qxFtAn #DiabetesCare #GestationalDiabetesMellitus #GDM #glycemia #glycatedalbumin #womenshealth

Placental hypoxia, high nighttime blood pressure, and maternal health. Hypertension disorders during pregnancy (HDP) have a wide range of severities, from clinical conditions with mild or no consequence for the mother and fetus, to life-threatening ones, with the development of preeclampsia and eclampsia as the main complication (PE). PE is the leading cause of neonatal and maternal morbidity and mortality worldwide. Office blood pressure (BP) and proteinuria have traditionally been used to identify PE. However, clinical hypertension and overt proteinuria are late manifestations of a physiopathological chain of events initiated for placental ischemia, being fetal growth restriction and a systemic inflammatory state in the mother with multiorgan damage the main consequences. Identifying these women with high risk of poor maternal and neonatal outcomes is an essential but challenging clinical task and different approaches have been proposed in the last years. https://lnkd.in/gg52nsUh AWHONN January 5, 2024 Attorneys, do you have a client that who has suffered pregnancy complications?!?! If so, who is interpreting your medical records and identifying the red flags of your current case?!?! Standing by for your medical legal needs. IG:cclegalnurse Email: [email protected] Mobile: (970)361-0201 #cclnc #floridaattorneys #laboranddelivery #newborn #Makeorbreakthecase #Healthcare #birthinjuries

🌟 Preeclampsia: Understanding, Awareness, and Support 🌟 As we celebrate Mother's Day and the joy of parenthood, it's crucial to shine a light on a serious yet often overlooked issue: Preeclampsia. This condition affects approximately 5-8% of pregnancies worldwide, making it a significant concern for expectant mothers and healthcare providers alike. What exactly is Preeclampsia? It's a complex condition characterized by high blood pressure and often accompanied by protein in the urine after 20 weeks of pregnancy. While the exact cause remains unknown, factors such as genetics, immune system dysfunction, and insufficient blood flow to the uterus may contribute to its development. The implications of Preeclampsia extend far beyond pregnancy. Left untreated, it can lead to serious complications for both mother and baby, including organ damage, stroke, eclampsia (seizures), preterm birth, and even maternal or fetal death. That's why early detection and proper management are absolutely critical. So, what can we do to support those affected by Preeclampsia? First and foremost, education is key. By understanding the signs and symptoms, expectant mothers can advocate for their own health and seek timely medical attention if needed. Additionally, healthcare providers play a vital role in routine prenatal care, monitoring blood pressure, and conducting urine tests to identify any red flags. Beyond awareness, it's essential to foster a supportive environment for those navigating Preeclampsia. Whether you're a colleague, friend, or family member, offering a listening ear, providing practical assistance, or simply showing empathy can make a world of difference during this challenging time. #PreeclampsiaAwareness #MaternalHealth #SupportMothers 🤰

PCOS IN THE NEWS - https://lnkd.in/e4vNn_Ab Have you been taking Ozempic or Wegovy? WHAT YOU SHOULD KNOW Some women using GLP-1 medications for weight loss, such as Ozempic and Wegovy, have reported unexpected pregnancies. While these medications are primarily for managing obesity and diabetes, emerging anecdotes suggest they might also affect fertility. Given the lack of comprehensive data on their safety during pregnancy, this topic is garnering attention among researchers and healthcare providers. WHAT YOU CAN DO If you are taking GLP-1 medications and considering pregnancy: - Consult with Your Doctor: Discuss the timing for possibly stopping the medication based on current medical guidance and your health status. - Follow Drug Labels and Medical Advice: Adhere to specific instructions about medication use relative to pregnancy planning, such as discontinuing the drug a recommended period before trying to conceive. - Stay Informed: Keep up with the latest studies and FDA updates regarding the use of these medications during pregnancy. Consider participating in registries or studies that track pregnancy outcomes among users of GLP-1 medications to help gather vital data. Navigating the unexpected implications of GLP-1 medications on fertility underscores the importance of informed medical consultation and active participation in new research. Thank you to the PCOS Challenge Scientific Advisory Board members, Drs. Melanie Cree and Ricardo Azziz, who contributed to this article. STAY CONNECTED Follow us and join the FREE PCOS Challenge Support Network with over 60,000 members at PCOSChallenge.com. #pcos #pcoschallenge #pcossupport #health #womenshealth #adolescenthealth #mentalhealth #maternalhealth #hearthealth #fertility